Canarys Automa. (CANARYS)

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Revenue growth of 169.29% and profit growth of 62.71% show strong momentum.
• P/E of 12.22 and PEG of 0.11 leave room for upside if growth continues.
• Promoter holding of 57.28% aligns management with minority shareholders.
• Piotroski F-Score of 7/9 suggests solid near-term financial health.
• Latest quarter sales of ₹101 Cr with net profit of ₹9 Cr indicates operating traction.

Concerns

• N/A book value, ROE, and debt/equity data make it impossible to assess balance-sheet quality and leverage.
• Zero dividend means total return depends entirely on future earnings growth.
• Very high sales growth of 169.29% may be transient or a low-base effect for a ₹134 Cr market-cap company.
• Price is roughly 41% below the 52-week high, signalling market scepticism about sustainability.

AI Analysis

Let me focus on what the numbers tell me. Canarys Automa is a ₹134 Cr software and consulting company, so it’s a small fish. At ₹20.90, it sits 40% below its 52-week high of ₹35.20. I like buying depressed prices, but only when the underlying business deserves confidence. The headline growth is striking: sales up 169.29% and profit up 62.71%. The trailing P/E is just 12.22, and the PEG is 0.11. If these growth rates were durable, this would be a screaming bargain. But durable is the key word. The latest quarter shows ₹101 Cr of sales and ₹9 Cr of net profit, a net margin near 9%. ROCE is 14.36%, acceptable but hardly the mark of a wide-moat franchise. In software consulting, competitive advantage often lies in reputation, client relationships, and switching costs; the figures provided cannot prove any of that. The promoter holding of 57.28% is encouraging, and a Piotroski score of 7/9 indicates decent financial health. Still, the absence of book value, ROE, and debt/equity data worries me. Graham insisted on understanding the balance sheet before buying a stock. A zero dividend means the investor must rely entirely on future earnings growth. Mr. Market may be sceptical for a reason; the stock is far from its high despite huge reported growth. If the growth is real and sustainable, this is the kind of neglected small-cap that could reward patient shareholders. I would demand several more quarters of proof. I would not bet the farm on a single stack of ratios.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer